The similar pattern and extent of modifications in all the patients and the absence of correlations between any of the transcription factors and patients characteristics, including age, age at onset, disease duration, LED, and UPDRS part III score, suggests that modification of CD4+ T cell differentiation mechanisms is independent from PD progression and severity, and insensitive to drug treatments. The gene discussed is CD4; the disease is Parkinson disease.